Overall Status

Recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 2 (1)

phase 2/phase 3 (1)

Sponsor

Cancer Research UK (1)

Eisai Inc. (1)

Collaborator

Hoffmann-La Roche (1)

Royal Marsden NHS Foundation Trust (1)

University of Birmingham (1)

University of Manchester (1)

Intervention

cobimetinib (1)

lenvatinib 24 mg (1)

vemurafenib (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

thyroid carcinoma, anaplastic

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Solid Tumor, Haematological Malignancy, Melanoma Trial in United Kingdom (Vemurafenib, Cobimetinib)

Recruiting

Solid Tumor
+11 more

Belfast, United Kingdom
+16 more

Mar 2, 2023

Thyroid Carcinoma, Anaplastic Trial in Worldwide (Lenvatinib 24 mg)

Terminated

Thyroid Carcinoma, Anaplastic

Lenvatinib 24 mg

Scottsdale, Arizona
+29 more

Sep 25, 2019